Mustard Seed Investor logo: a sprouting mustard seedMustard Seed Investor
← All stocks
No tickerHealth CareCommon Stock

Terns Pharmaceuticals Inc

Held by 0 tracked managers as of Q2 2026 · CUSIP ⓘCUSIP: A 9-character ID for one specific security - one share class of one company, or one bond. Tickers can change and can mean different things in different countries; a CUSIP always identifies exactly the same security, which is why filings use it. Guide 880881107 · Sector ⓘGICS sectors: The 11-sector system most investors know (Global Industry Classification Standard): Technology, Health Care, Financials and so on. This site assigns each company a GICS-style sector from its SIC code, with a few hand corrections, so sector pages match the names investors expect. Guide

Download report
In plain English: 0 of the investors we track own this stock. In the latest quarter, 0 of them bought more of it and 10 sold some or all of theirs. That tells you what they did last quarter — not what the stock will do next.

Educational and informational only, not personalized investment advice. Based on public filings that may be delayed or contain errors; verify with the original filings. Disclaimer

Managers holding
0
-10 vs last quarter (like-for-like)
Total value held
$0
Across tracked managers
Average weight ⓘOn average, how big this stock is in the portfolios that own it (its share of each manager's reported portfolio value).
—
Of each manager's book
QoQ value ⓘLike-for-like: only managers that filed both quarters are compared, so a manager filing late (or confidentially) does not look like buying or selling. Includes price changes.
-$381.83M
-100.0% vs last quarter
Net shares bought
-7.2M
Est. net flow -$381.83M
Quarter activity
0 bought · 10 sold
0 new · 10 sold out

Tracked capital in this stock

Total value held (area) and number of managers (line). Dips can mean a large holder filed that quarter confidentially (e.g. Norges Bank in Q1/Q3).

Chart: Tracked capital in this stock

Aggregate buying and selling

Net share change reported each quarter

Chart: Aggregate buying and selling

Who owns Terns Pharmaceuticals Inc?

🔒 The 'who added and who trimmed' chart is a Plus feature

You're viewing the Free plan. Upgrade to unlock The 'who added and who trimmed' chart — every paid plan starts with a 7-day free trial, and you can cancel in two clicks.

See plans & upgrade Sign in

Who owns Terns Pharmaceuticals Inc? — Q2 2026

Holders ranked by position size, with each one's quarter-over-quarter change.

CSV Excel
All Only new positions Only increased Only reduced
Column filters

Numbers accept 1.5M, 2B, 250K. Percent columns take percent (5 = 5%).

Nothing to show yet.

Sold out completely this quarter

CSV Excel
Column filters

Numbers accept 1.5M, 2B, 250K. Percent columns take percent (5 = 5%).

Manager Fund Shares sold Value last quarter ↓
Ken Griffin Citadel Advisors -3.2M $169.70M
Israel Englander Millennium Management -3.0M $158.77M
George Soros Soros Fund Management -321.9K $16.97M
David Shaw D.E. Shaw & Co. -201.2K $10.61M
Cliff Asness AQR Capital Management -171.6K $9.04M
Jim Simons Renaissance Technologies -169.0K $8.91M
Two Sigma Two Sigma Investments -54.4K $2.87M
Fred Alger Fred Alger Management -47.2K $2.49M
Ron Baron Baron Capital (BAMCO) -35.0K $1.85M
Bridgeway Bridgeway Capital Management -12.0K $632.64K

Politician trades

Politician trades in this stock

CSV Excel
Chamber BothHouseSenate
Party AllDemocratsRepublicansIndependents
Traded Any timeLast 30 daysLast 90 daysLast 12 months
All Purchases Sales Exchanges Large: $50K+ Very large: $250K+ Filed late (45+ days)
Column filters

Numbers accept 1.5M, 2B, 250K. Percent columns take percent (5 = 5%).

No politician trades match these filters.